IgA-nefropátia trials, also abroad
93 open IgA-nefropátia trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Kína | 53 |
| Egyesült Államok | 27 |
| Spanyolország | 12 |
| Franciaország | 12 |
| Egyesült Királyság | 12 |
| All other countries |
The same trial often runs in several countries
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy has 1 site in Szingapúr and runs in 36 countries. If a site near you is full, another one may still take people.
See A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy in all 36 countries